PharmacoEconomics

NICE Says No to Inhaled Insulin: What Lessons Should We Learn?
pp. 627-629(3)
Author: Freemantle, Nick

Economic Models of Antiretroviral Therapy: Searching for the Optimal Strategy
pp. 631-642(12)
Author: Hellinger, Fred J.

Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues
pp. 643-650(8)
Authors: Yin Bun Cheung,; Thumboo, Julian

Cost of Lung Cancer: A Methodological Review
pp. 651-659(9)
Authors: Molinier, Laurent; Combescure, Christophe; Chouaïd, Cristos; Daurès, Jean-Pierre; Housset, Bruno; Fabre, Didier; Grand, Alain; Vergnenègre, Alain

Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies
pp. 661-672(12)
Author: Wong, John B.

Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country
pp. 673-682(10)
Authors: Wee, Hwee-Lin; Tan, Chee-Eng; Goh, Su-Yen; Li, Shu-Chuen

Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation
pp. 683-694(12)
Authors: Voshaar, Richard C. Oude; Krabbe, Paul F.M.; Gorgels, Wim J.M.J.; Adang, Eddy M.M.; van Balkom, Anton J.L.M.; Eloy H. van de Lisdonk,; Zitman, Frans G.

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma
pp. 695-708(14)
Authors: Johansson, Gunnar; Andreasson, Emma B.; Larsson, Per E.; Vogelmeier, Claus F.

Clopidogrel: A Pharmacoeconomic Review of its Use in Patients with Non-ST Elevation Acute Coronary Syndromes
pp. 709-726(18)
Authors: Lyseng-Williamson, Katherine A.; Plosker, Greg L.